Related Experiment Videos
Mechanisms of APC-driven tumorigenesis: lessons from mouse models
1MGC Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. fodde@ruly46.medfac.leidenuniv.nl
Cytogenetics and Cell Genetics
|November 5, 1999
Summary
The adenomatous polyposis coli (APC) gene is crucial for colorectal cancer development. Mouse models reveal insights into APC-driven tumorigenesis, highlighting genetic and phenotypic variability in both mice and humans.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Colorectal cancer (CRC) is a leading cause of death globally.
- The adenomatous polyposis coli (APC) gene, linked to familial adenomatous polyposis (FAP), acts as a critical regulator of colonic epithelial cell proliferation.
- APC mutations are prevalent in sporadic CRC and initiate tumor development in humans and mice.
Purpose of the Study:
- To review available animal models for FAP.
- To explore genotype-phenotype correlations in APC-driven colorectal tumorigenesis.
- To propose a hypothetical model for APC-driven tumor formation considering observed variability.
Main Methods:
- Review of existing literature on FAP and APC gene function.
- Analysis of data from genetically engineered mouse models of FAP.
- Comparison of phenotypic variability in human FAP patients and mouse models.
Main Results:
- APC gene inactivation is an early event in colorectal tumor development.
- Animal models confirm genotype-phenotype correlations in FAP but also highlight variability.
- Significant phenotypic variability exists among individuals with identical APC mutations.
Conclusions:
- APC is a key gatekeeper gene in colorectal cancer.
- Mouse models are valuable tools for studying CRC pathogenesis and genetic variability.
- Understanding variability in APC-driven tumorigenesis is essential for developing effective therapeutic strategies.